Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boron-based gel for prevention and treatment of radiation dermatitis
IRCT20190305042925N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2019
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sodium pentaborate pentahydrate in radiodermatitis (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Radiation-induced skin reactions. Started Feb 2019; status: completed.
02
Drugs
sodium pentaborate pentahydrate
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on IRCT20190305042925N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190305042925N1.